1,3-dipropyl-8-cyclopentylxanthine has been researched along with Ventricular Fibrillation in 2 studies
DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.
Ventricular Fibrillation: A potentially lethal cardiac arrhythmia that is characterized by uncoordinated extremely rapid firing of electrical impulses (400-600/min) in HEART VENTRICLES. Such asynchronous ventricular quivering or fibrillation prevents any effective cardiac output and results in unconsciousness (SYNCOPE). It is one of the major electrocardiographic patterns seen with CARDIAC ARREST.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chi, L | 1 |
Friedrichs, GS | 1 |
Oh, JY | 1 |
Green, AL | 1 |
Lucchesi, BR | 1 |
Schreieck, J | 1 |
Richardt, G | 1 |
2 other studies available for 1,3-dipropyl-8-cyclopentylxanthine and Ventricular Fibrillation
Article | Year |
---|---|
Effect of Ado A1- and A2-receptor activation on ventricular fibrillation during hypoxia-reoxygenation.
Topics: Action Potentials; Adenosine; Animals; Electrolytes; Heart; Homeostasis; In Vitro Techniques; Kineti | 1994 |
Endogenous adenosine reduces the occurrence of ischemia-induced ventricular fibrillation in rat heart.
Topics: Adenine; Adenosine; Aminoimidazole Carboxamide; Animals; Caffeine; Creatine Kinase; Electrocardiogra | 1999 |